Anixa Biosciences Inc — Director's Dealing 2014

Jan 23, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2014-01-21

Reporting Person: KUMAR AMIT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-21	Common Stock	P	9000	$0.204	Acquired	102004	Direct
2014-01-21	Common Stock	P	15000	$0.208	Acquired	117004	Direct
2014-01-21	Common Stock	P	26000	$0.2099	Acquired	143004	Direct
2014-01-21	Common Stock	P	39300	$0.21	Acquired	182304	Direct
2014-01-21	Common Stock	P	10000	$0.215	Acquired	192304	Direct
2014-01-21	Common Stock	P	700	$0.2199	Acquired	193004	Direct